海森药业
(001367)
| 流通市值：8.70亿 | | | 总市值：34.15亿 |
| 流通股本：3870.89万 | | | 总股本：1.52亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 859,080,388.92 | 1,034,482,112.28 | 723,685,939.41 | 700,713,307.83 |
| 应收票据及应收账款 | 53,477,235.51 | 57,785,937.67 | 41,175,208.18 | 49,583,231.04 |
| 其中：应收票据 | 1,161,634.98 | 4,282,530.64 | 5,487,758 | 6,270,382 |
| 应收账款 | 52,315,600.53 | 53,503,407.03 | 35,687,450.18 | 43,312,849.04 |
| 应收款项融资 | 24,880,411.39 | 31,417,799 | 21,979,506.7 | 23,429,158.35 |
| 预付款项 | 4,231,973.72 | 3,285,364.2 | 4,835,683.9 | 3,013,785.96 |
| 其他应收款合计 | 202,654.9 | 78,521.47 | 253,753.9 | 188,042.84 |
| 存货 | 115,771,345.94 | 115,478,661.89 | 141,420,720.12 | 150,147,978.43 |
| 其他流动资产 | 15,409,801.39 | 15,095,945.31 | 15,740,989.71 | 14,007,547.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,243,053,811.77 | 1,257,624,341.82 | 1,199,091,801.92 | 1,191,083,051.87 |
| 非流动资产: | | | | |
| 投资性房地产 | 3,786,774.07 | 3,858,590.38 | 3,930,406.69 | 4,006,163.41 |
| 固定资产 | 116,148,894.44 | 119,566,404.42 | 111,539,533.3 | 107,717,447.98 |
| 在建工程 | 84,452,141.39 | 73,592,558.64 | 54,963,086.9 | 43,167,612.96 |
| 使用权资产 | 7,974,549.47 | 8,352,288.77 | 8,463,228.07 | 8,411,924.9 |
| 无形资产 | 19,939,073.37 | 20,141,826.15 | 19,493,593.75 | 19,666,879.06 |
| 长期待摊费用 | 183,010.59 | 265,792.01 | 385,139 | 101,973.79 |
| 其他非流动资产 | 30,395,839.02 | 2,589,942.41 | 1,573,625.21 | 3,795,608.69 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 262,880,282.35 | 228,367,402.78 | 200,348,612.92 | 186,867,610.79 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,505,934,094.12 | 1,485,991,744.6 | 1,399,440,414.84 | 1,377,950,662.66 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 49,055,130.34 | 52,156,056.44 | 31,423,874.56 | 37,204,794.28 |
| 应付账款 | 49,055,130.34 | 52,156,056.44 | 31,423,874.56 | 37,204,794.28 |
| 合同负债 | 8,058,970.87 | 7,918,386.3 | 9,457,258.23 | 14,332,436.49 |
| 应付职工薪酬 | 8,100,396.04 | 15,932,283.21 | 11,781,649.61 | 10,326,667.96 |
| 应交税费 | 9,605,634.04 | 10,840,832.63 | 8,742,183.94 | 7,914,668.91 |
| 其他应付款合计 | 29,900,290.59 | 30,756,281.89 | 5,937,101.33 | 6,346,070.12 |
| 一年内到期的非流动负债 | 1,135,844.35 | 1,135,844.35 | 953,956.74 | 1,138,480.51 |
| 其他流动负债 | 860,322.77 | 3,300,318.18 | 5,255,544.74 | 5,153,547.97 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 106,716,589 | 122,040,003 | 73,551,569.15 | 82,416,666.24 |
| 非流动负债: | | | | |
| 租赁负债 | 7,066,592.93 | 6,981,659.93 | 8,385,159.91 | 7,834,605.64 |
| 递延收益 | 5,113,507.54 | 5,386,779.46 | 5,663,087.58 | 5,663,087.58 |
| 递延所得税负债 | 6,493,222.83 | 7,428,645.01 | 8,874,065.07 | 7,898,282.79 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 18,673,323.3 | 19,797,084.4 | 22,922,312.56 | 21,395,976.01 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 125,389,912.3 | 141,837,087.4 | 96,473,881.71 | 103,812,642.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 102,653,000 | 102,653,000 | 100,640,000 | 100,640,000 |
| 资本公积 | 764,744,681.68 | 759,967,329.46 | 730,380,230.3 | 730,380,230.3 |
| 减:库存股 | 25,464,450 | 25,464,450 | - | - |
| 专项储备 | 1,773,171.7 | 1,373,180.89 | 1,928,299.05 | 2,009,476.96 |
| 盈余公积 | 54,410,850.18 | 54,410,850.18 | 41,682,014.06 | 41,682,014.06 |
| 未分配利润 | 482,426,928.26 | 451,214,746.67 | 428,335,989.72 | 399,426,299.09 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,380,544,181.82 | 1,344,154,657.2 | 1,302,966,533.13 | 1,274,138,020.41 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,380,544,181.82 | 1,344,154,657.2 | 1,302,966,533.13 | 1,274,138,020.41 |
| 负债和股东权益合计 | 1,505,934,094.12 | 1,485,991,744.6 | 1,399,440,414.84 | 1,377,950,662.66 |
| 公告日期 | 2025-04-26 | 2025-03-28 | 2024-10-18 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |